Literature DB >> 20431274

Chloracne, a misnomer and its implications.

J H Saurat, O Sorg.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20431274     DOI： 10.1159/000290672

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  5 in total

1.  Selective Ah receptor ligands mediate enhanced SREBP1 proteolysis to restrict lipogenesis in sebocytes.

Authors:  Gulsum E Muku; Nicholas Blazanin; Fangcong Dong; Philip B Smith; Diane Thiboutot; Krishne Gowda; Shantu Amin; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2019-06-21       Impact factor: 4.849

Review 2.  Endocrine-disrupting chemicals and skin manifestations.

Authors:  Qiang Ju; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

3.  In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner.

Authors:  Nicolò Costantino Brembilla; Jean-Marie Ramirez; Rachel Chicheportiche; Olivier Sorg; Jean-Hilaire Saurat; Carlo Chizzolini
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

4.  Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice.

Authors:  Matthias Schäfer; Ann-Helen Willrodt; Svitlana Kurinna; Andrea S Link; Hany Farwanah; Alexandra Geusau; Florian Gruber; Olivier Sorg; Aaron J Huebner; Dennis R Roop; Konrad Sandhoff; Jean-Hilaire Saurat; Erwin Tschachler; Marlon R Schneider; Lutz Langbein; Wilhelm Bloch; Hans-Dietmar Beer; Sabine Werner
Journal:  EMBO Mol Med       Date:  2014-02-06       Impact factor: 12.137

5.  Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.

Authors:  Alison R Forrester; Martina S Elias; Emma L Woodward; Mark Graham; Faith M Williams; Nick J Reynolds
Journal:  J Dermatol Sci       Date:  2013-09-11       Impact factor: 4.563
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.